Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity - Suzuki, E; Kapoor, V; Jassar, A S; Kaiser, L R; Albelda, S M (Clin Cancer Res, 2005)